Pathfinder Cell Therapy, Inc.

OTCPK:PFND Stock Report

Market Cap: US$667.0

Pathfinder Cell Therapy Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Rick Franklin

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12.6yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure12.6yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Rick Franklin (78 yo)

12.6yrs

Tenure

US$120,000

Compensation

Dr. Richard L. Franklin, also known as Rick, M.D., Ph D., is the Founder of Pathfinder Cell Therapy, Inc. and has been its Chief Executive Officer, Secretary and President since September 2011. Dr. Frankli...


Board Members

NamePositionTenureCompensationOwnership
Joerg Gruber
Founder & Chairman17yrsUS$20.00kno data
Richard Franklin
Founder23.3yrsUS$120.00kno data
John Brooks
Independent Director12.6yrsUS$20.00kno data
John Alam
Independent Director12.6yrsUS$20.00kno data
Zen Chu
Independent Director12.6yrsUS$20.00kno data
Brock Reeve
Director12.6yrsUS$20.00kno data

12.6yrs

Average Tenure

63.5yo

Average Age

Experienced Board: PFND's board of directors are seasoned and experienced ( 12.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.